We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack (389801)

ARTG ID 389801

ARTG Name

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

Product name

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

ARTG Date

20 July 2022

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

nirmatrelvir

ritonavir

Licence category

RE

Licence status

A

Summary

Product information

Related information

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack (2023-24)

2023-24

Annual charge exemption

Exempt from annual charge in 2023-24 due to Pfizer Australia Pty Ltd declaring $0 turnover in that period.
PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack, Pfizer Australia Pty Ltd, CON-1178

14 November 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 14 November 2023 until 30 June 2024.
PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack, Pfizer Australia Pty Ltd, CON-971

20 July 2022

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective for all batches released for supply from the 20 July 2022 until 20 January 2024.